This brand name is authorized in Nigeria.
The drug JAMBACT contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
826Y60901U - BETAMETHASONE DIPROPIONATE
|
|
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
2
|
UNII
G07GZ97H65 - CLOTRIMAZOLE
|
|
Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc. |
|
3
|
UNII
8X7386QRLV - GENTAMICIN SULFATE
|
|
Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-101267 | Cream | Jambact Cream CREAM 0.05%; 1%; 0.1% 1 x 30 g | Cream JAMBACT CREAM Betamethasone Dipropionate USP Equivalent to Betamethasone (0.05 % W/W) - Clotrimazole USP (1.0 % W/W) - Gentamicin Sulphate BP Equivalent to Gentamicin (0.1 % W/W) CLOTRIMAZOLE BP - 1.00%W/W, GENTAMICIN 0.10% W/W, BECLOMETHASONE DIPROPIONATE 0.025% W/W, TONAFTATE 1.00W/W, CREAM BASE Q.S. A4-101267 Drugs Imported Product 30gm 08-08-2024 JAMIN INTERNATIONAL COMPANY. LIMITED, 26 BASDEN STREET FEGGE , ONITSHA 08077261675 jaminpharma@yahoo.com "Medico Remedies Limited, Plot Nos. 8 & 9, Dewan & Sons Udyog Nagar, Lokmanya Nagar, Palgar (West), Thane 401404 Maharashtra State, India" | 30/04/2025 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D07AC01 | Betamethasone | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III) |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-101267 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.